Brian Nowosielski

Researchers measured current pharmacy practices and the future potential of practices geared toward reducing instances of opioid overdose.

Researchers conducted a survey of community pharmacists to understand their use, concerns, and opportunities regarding ChatGPT technology in their practice setting.

Patients with musculoskeletal pain were treated with cryotherapy spray to assess its use in providing immediate and sustained pain relief.

Patients prescribed high-dose opioids were given the option to switch to buprenorphine in hopes of improving pain and reducing opioid dosage.

Researchers investigate the effects of subanesthetic doses of esketamine for the treatment of pain and cognition in patients undergoing surgery.

Among a diverse cohort of patients with type 2 diabetes (T2D), researchers examined the use of automated insulin delivery for lowering hemoglobin A1c levels.

Pharmacy industry experts gathered for a webinar detailing the upcoming trends expected to take shape in 2025.

Erin Fox, PharmD, MHA, BCPS, FASHP, joined Drug Topics to discuss ultra-high-cost drugs and the American Society of Health-System Pharmacists 2025 Pharmacy Forecast.

For patients with atopic dermatitis reporting moderate-to-severe scratching, researchers explored the efficacy of an AI-enabled wearable sensor with closed-loop haptic feedback.

Cardiovascular health is known to be associated with the probability of having active or developing migraine in the future.

Crystal Zhou, PharmD, APh, AHSCP, BCACP, discussed her role as Lead Pharmacist of the Cut Hypertension Program.

Researchers conducted a review of clinical studies to better understand non-oral drugs for the treatment of pain related to herpes zoster.

Researchers asked adults with chronic pain and physicians their opinions on cannabis regulations.

Assessing the management of chronic low back pain, researchers compared outcomes of healthy lifestyle care with current guideline-recommended care.

The American Pharmacists Association announced the launch of its transformative HealthShifts platform in collaboration with the California Pharmacists Association and powered by Locumate.

Researchers addressed unmet needs in the treatment of chronic pain for patients living with axial spondyloarthritis.

Experts believe a bird flu outbreak is responsible for hundreds of dead birds washing ashore on the beaches of Chicago.

Jonathan Watanabe, PharmD, MS, PhD, BCGP, discussed gaps within primary care in the context of the American Society of Health-System Pharmacists 2025 Pharmacy Forecast.

In a network meta-analysis, researchers compared the safety and efficacy of available analgesic treatment for treating acute pain in children.

Researchers conducted a population-based study of women in Korea to analyze the association between age at menopause and incidence of type 2 diabetes.

Scott Nelson, PharmD, MS, FAMIA, ACHIP, joined Drug Topics to discuss the 2025 Pharmacy Forecast and AI’s role in the future of pharmacy practice.

As a new presidential administration begins to take shape, experts are curious about its promises of potential PBM reform within the pharmacy benefits industry.

In a systematic review, researchers explored how biofeedback impacted rehabilitation in patients experiencing chronic pain disorders.

Eric Tichy, PharmD, MBA, BCPS, FCCP, FAST, discussed tactics and challenges health-system pharmacy encounters within the distribution of patient benefits.

Researchers addressed the factors leading to and the rates of discontinuation and reinitiation of GLP-1 RAs among adults with obesity.

Erin Fox, PharmD, MHA, BCPS, FASHP, joined Drug Topics to explore ultra-high-cost drugs and pharmacists’ role in managing patients’ prescription regimens.

In their exploration of 2 separate respiratory virus seasons, researchers examined the severity of illness for SARS-CoV-2, influenza, and respiratory syncytial virus.

Tocilizumab-anoh is the biosimilar formulation for ACTEMRA, a medication used to treat rheumatoid arthritis, COVID-19, and other diseases.

A survey conducted by 3 Axis Advisors revealed potential impacts of the Inflation Reduction Act’s Medicare Drug Price Negotiation Program.

Joseph DiPiro, PharmD, FCCP, FAAAS, broke down the importance of the ASHP Pharmacy Forecast and the process in which its content is curated.